“Accident and health insurer” has the meaning given to that term in Section 126.2
of the Illinois Insurance Code.
“Eligible patient” means a person who:
(1) has a terminal illness;
(2) has considered all other treatment options approved by the United States Food
and Drug Administration;
(3) has received a prescription or recommendation from his or her physician for an
investigational drug, biological product, or device;
(4) has given his or her informed consent in writing for the use of the investigational
drug, biological product, or device or, if he or she is a minor or lacks the mental
capacity to provide informed consent, a parent or legal guardian has given informed
consent on his or her behalf; and
(5) has documentation from his or her physician indicating that he or she has met
the requirements of this Act.
“Investigational drug, biological product, or device” means a drug, biological product, or device that has successfully completed Phase
I of a clinical trial, but has not been approved for general use by the United States
Food and Drug Administration.
“Phase I of a clinical trial” means the stage of a clinical trial where an investigational drug, biological product,
or device has been tested in a small group for the first time to evaluate its safety,
determine a safe dosage range, and identify side effects.
“Terminal illness” means a disease that, without life-sustaining measures, can reasonably be expected
to result in death in 24 months or less.
FindLaw Codes may not reflect the most recent version of the law in your jurisdiction. Please verify the status of the code you are researching with the state legislature or via Westlaw before relying on it for your legal needs.
Was this helpful?
Welcome to FindLaw's Cases & Codes
A free source of state and federal court opinions, state laws, and the United States Code. For more information about the legal concepts addressed by these cases and statutes, visit FindLaw's Learn About the Law.